Клиническая и экспериментальная тиреоидология

Расширенный поиск

Современные методы определения антител к рецептору ТТГ в диагностике и лечении болезни Грейвса

Полный текст:

Об авторе

V V Fadeev

доктор мед. наук, зам. директора по научной работе Эндокринологического научного центра, профессор кафедры эндокринологии Первого МГМУ им. И.М. Сеченова

Список литературы

1. Фадеев В.В., Абрамова Н.А., Прокофьев С.А. и др. Антитела к рецептору ТТГ в дифференциальной диагностике токсиче ского зоба. Пробл. эндокринол. 2005; 51 (4): 10–18.

2. Adams D.D., Purves H.D. Abnormal responses in the assay of thy rotropin. Proc. Univ. Otago Med. Sch. 1956; 34: 11–12.

3. AmbesiImpiombato F.S., Parks L., Coon H.G. Culture of hormone dependent epithelial cells from rat thyroids. Proc. Natl. Acad. Sci USA. 1980; 77: 3455–3459.

4. Costagliola S., Morgenthaler N.G., Hoermann R. et al. Second gen eration assay for thyrotropin receptor antibodies has superior diag nostic sensitivity for Graves’ disease. J. Clin. Endocrinol. Metab. 1999; 84: 90–97.

5. De Groot L., Abalovich M., Alexander E.K. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2012; 97 (8): 2543–2565.

6. Eckstein A.K., Plicht M., Lax H. et al. Clinical results of anti inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Clin. Endocrinol. (Oxf.). 2004; 61 (5): 612–618.

7. Kamijo K., Murayama H., Uzu T. et al. A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin recep tor (mc4) is more useful in differentiation of Graves’ disease from painless thyroiditis than conventional thyrotropinstimulating anti body assay using porcine thyroid cells. Thyroid. 2010; 20: 851–856.

8. Kaneko T., Zor U., Field J.B. Stimulation of thyroid adenyl cyclase activity and cyclic adenosine 3959monophosphate by longacting thyroid stimulator. Metabolism. 1970; 19: 430–438.

9. Kasagi K., Konishi J., Arai K. et al. A sensitive and practical assay for thyroidstimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J. Clin. Endo crinol. Metab. 1986; 62: 855–862.

10. Lee J., Jang H., Kim S. et al. Diagnostic value of a chimeric TSH receptor (Mc4)based bioassay for Graves’ disease. Korean J. Intern. Med. 2011; 26: 179–186.

11. Leschik J.J., Diana T., Olivo P.D. et al. Analytical performance and clinical utility of a bioassay for thyroidstimulating immunoglobu lins. Am. J. Clin. Pathol. 2013; 139 (2): 192–200.

12. Lytton S.D., Ponto K.A., Kanitz M. et al. A novel thyroid stimulat ing immunoglobulin bioassay is a functional indicator of activity and severity of Graves’ orbitopathy. J. Clin. Endocrinol. Metab. 2012; 95: 2123–2131.

13. Manley S.W., Bourke J.R., Hawker R.W. The thyrotrophin recep tor in guineapig thyroid homogenate: Interaction with the long acting thyroid stimulator. J. Endocrinol. 1974; 61: 437–445.

14. Meek J.C., Jones A.E., Lewis U.J., Vanderlaan W.P. Characteri zation of the longacting thyroid stimulator of Graves’ disease. Proc. Natl. Acad. Sci USA. 1964; 52: 342–349.

15. Michelangeli V., Poon C., Taft J. et al. The prognostic value of thy rotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs. Thyroid. 1998; 8: 119–124.

16. Nagayama Y., Wadsworth H.L., Russo D. et al. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoanti bodies determined with chimeric TSHlutropin/chorionic gonadotropin receptors. J. Clin. Invest. 1991; 88: 336–340.

17. Onaya T., Kotani K., Yamada T., Ochi Y. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. J. Clin. Endocrinol. Metab. 1973; 36: 859–866.

18. Orgiazzi J. AntiTSH receptor antibodies in clinical practice. Endocrinol. Metab. Clin. N. Am. 2000; 29: 339.

19. Orgiazzi J., Williams D.E., Chopra I.J., Solomon D.H. Human thy roid adenyl cyclasestimulating activity in immunoglobulin G of patients with Graves’ disease. J. Clin. Endocrinol. Metab. 1976; 42: 341–354.

20. Pastan I., Roth J., Macchia V. Binding of hormone to tissue: the first step in polypeptide hormone action. Proc. Natl. Acad. Sci USA. 1966; 56: 1802–1809.

21. Pedersen I.B., Handberg A., Knudsen N. et al. Assays for thyroid stimulating hormone receptor antibodies employing different lig ands and ligand partners may have similar sensitivity and specifici ty but are not interchangeable. Thyroid 2010; 20 (2): 127–133.

22. Pedersen I.B., Knudsen N., Perrild H. et al. TSHreceptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two compet itive binding assays. Clin. Endocrinol. (Oxf.). 2001; 55 (3): 381–390.

23. Saravanan P., Dayan C.M. Thyroid autoantibodies. J. Clin. Endocrinol. Metab. 2001; 30 (2): 315–337.

24. Schott M., Hermsen D., BroeckerPreuss M. et al. Clinical value of the first automated TSH receptor autoantibody assay for the diag nosis of Graves’ disease: an international multicentre trial. Clin. Endocrinol. (Oxf.). 2008; 71: 566–573.

25. Schott M., Morgenthaler N.G., Fritzen R. et al. Levels of autoan tibodies against human TSH receptor predict relapse of hyper thyroidism in Graves' disease. Horm. Metab. Res. 2004; 36 (2): 92–96.

26. Smith Rees B., Hall R. Measurement of thyrotropin receptor anti bodies. Methods Enzymol. 1981; 74: 405–421. Smith Rees B., Hall R. Thyroidstimulating immunoglobulins in Graves’ disease. Lancet 1974; 2: 427–431.

27. Tamaki H., Amino N., Kimura M. et al. Low prevalence of thy rotropin receptor antibody in primary hypothyroidism in Japan. J. Clin. Endocrinol. Metab. 1990; 71: 1382.

28. Tozzoli R., Bagnasco M., Giavarina D., Bizzaro N. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and metaanalysis. Autoimmun. Rev. 2012; 12 (2): 107–113.

29. Vitti P., Elisei R., Tonacchera M. et al. Detection of thyroidstimu lating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J. Clin. Endocrinol. Metab. 1993; 76: 499–503.

30. Watson P.F., Ajjan R.A., Phipps J. et al. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves’ disease. Clin. Endocrinol. 1998; 49: 577–581.

31. Zoephel K., Gruening T., Roggenbuck D. et al. On specificity of 2nd generation TSH receptor autoantibody measurements. Clin. Lab. 2008; 54: 243–249.


Для цитирования:

Fadeev V.V. Современные методы определения антител к рецептору ТТГ в диагностике и лечении болезни Грейвса. Клиническая и экспериментальная тиреоидология. 2013;9(1):9-17.

For citation:

. Thyrotropin receptor antibodies assays in the management of Graves’ disease. Clinical and experimental thyroidology. 2013;9(1):9-17. (In Russ.)

Просмотров: 158

ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)